Learn how to create a beautiful handmade ring step by step with this simple and satisfying jewelry tutorial. Perfect for beginners and DIY jewelry lovers. #JewelryMaking #DIYRing #HandmadeJewelry ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

Antigen-presenting cells activate invariant natural killer T (iNKT) cells, and this combination with α-galactosylceramide subsequently activates the body’s own T cells to fight tumors. This image was ...

Subcutaneous mosunetuzumab with step-up dosing plus six cycles of polatuzumab vedotin enabled fully outpatient delivery without mandatory hospitalization, aligning with access and cost-reduction goals ...

Intratumor heterogeneity fundamentally challenges cancer treatment, as coexisting, molecularly distinct cell states with non-overlapping drug sensitivities can drive therapeutic resistance. We ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. The longtime Tiffany & Co.

Combo Devils, a recently kickstarted platform fighter from developer Punkzilla, has one of the best elevator pitches of any fighting game I’ve played in a hot minute: What if we took the core of Smash ...

Doc Rivers and Giannis Antetokounmpo are among many in the Milwaukee Bucks locker room looking for answers regarding their rotational moves for the remainder of the regular season. Jeff Hanisch / ...

Randomization enrolled 1841 systemic-therapy–naïve patients within 12 weeks post-surgery to 1 year pembrolizumab plus daily belzutifan or placebo. Disease-free survival improved despite unreached ...

Both trials are ongoing and will report on overall survival at a subsequent analysis. Findings showed the trial met its primary endpoint demonstrating a statistically significant and clinically ...

Private equity firm Cinven is considering a sale of German software company think-cell, which could be valued at as much as €3 billion ($3.5 billion) in a deal, according to people familiar with the ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the combination of lurbinectedin and atezolizumab as first-line maintenance treatment for ...